These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19373611)

  • 1. Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells.
    Yui S; Kanamoto R; Saeki T
    Nutr Cancer; 2009; 61(3):374-80. PubMed ID: 19373611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid.
    Yui S; Saeki T; Kanamoto R; Iwami K
    J Biochem; 2005 Aug; 138(2):151-7. PubMed ID: 16091589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells.
    Ignacio Barrasa J; Olmo N; Pérez-Ramos P; Santiago-Gómez A; Lecona E; Turnay J; Antonia Lizarbe M
    Apoptosis; 2011 Oct; 16(10):1054-67. PubMed ID: 21789651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycholic acid can induce apoptosis in the human colon cancer cell line HCT116 in the absence of Bax.
    Yui S; Kanamoto R; Saeki T
    Nutr Cancer; 2008; 60(1):91-6. PubMed ID: 18444140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
    Einarsson C; Hillebrant CG; Axelson M
    Hepatology; 2001 May; 33(5):1189-93. PubMed ID: 11343248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation.
    Saeki T; Yui S; Hirai T; Fujii T; Okada S; Kanamoto R
    Nutr Cancer; 2012; 64(4):617-26. PubMed ID: 22497644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling.
    Im E; Akare S; Powell A; Martinez JD
    Nutr Cancer; 2005; 51(1):110-6. PubMed ID: 15749637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
    Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis.
    McMillan L; Butcher S; Wallis Y; Neoptolemos JP; Lord JM
    Biochem Biophys Res Commun; 2000 Jun; 273(1):45-9. PubMed ID: 10873561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycholic acid and selenium metabolite methylselenol exert common and distinct effects on cell cycle, apoptosis, and MAP kinase pathway in HCT116 human colon cancer cells.
    Zeng H; Botnen JH; Briske-Anderson M
    Nutr Cancer; 2010; 62(1):85-92. PubMed ID: 20043263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bile acids on butyrate-sensitive and -resistant human colon adenocarcinoma cells.
    Pérez-Ramos P; Olmo N; Turnay J; Lecona E; de Buitrago GG; Portolés MT; Lizarbe MA
    Nutr Cancer; 2005; 53(2):208-19. PubMed ID: 16573382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
    Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
    Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies.
    Münch A; Ström M; Söderholm JD
    Scand J Gastroenterol; 2007 Oct; 42(10):1167-74. PubMed ID: 17852874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells.
    Fimognari C; Lenzi M; Cantelli-Forti G; Hrelia P
    Ann N Y Acad Sci; 2009 Aug; 1171():264-9. PubMed ID: 19723064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
    Horowitz NS; Hua J; Powell MA; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2007 Nov; 107(2):344-9. PubMed ID: 17720233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells.
    Merchant NB; Rogers CM; Trivedi B; Morrow J; Coffey RJ
    Surgery; 2005 Sep; 138(3):415-21. PubMed ID: 16213893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation.
    Martinez JD; Stratagoules ED; LaRue JM; Powell AA; Gause PR; Craven MT; Payne CM; Powell MB; Gerner EW; Earnest DL
    Nutr Cancer; 1998; 31(2):111-8. PubMed ID: 9770722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R; Chen J; Cong X; Hu S; Chen X
    J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells.
    Shiraki K; Ito T; Sugimoto K; Fuke H; Inoue T; Miyashita K; Yamanaka T; Suzuki M; Nabeshima K; Nakano T; Takase K
    Int J Mol Med; 2005 Oct; 16(4):729-33. PubMed ID: 16142412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.